In such case, our clinical data in NSCLC patients treated with conventional radiotherapy plus chemotherapy are in line with the preclinical data highlighting the role of radiotherapy in the proliferation of a stem like CD8+ T-cell population within TDLNs, with potential systemic anti-tumor effect. Here, CD8A is linked to neoplasm.